The America First Policy Institute released a statement on the Department of Health and Human Services’ new pro-patient rule that strengthens price transparency and expands patients’ ability to make informed decisions about their care.
@CharlieKatebi, AFPI’s Deputy Director of Healthy America, notes that the rule empowers patients by leveling the playing field between hospitals and independent physicians and by helping lower out-of-pocket costs. He highlights key reforms including Site Neutral Medicare payment policies, the removal of the Inpatient Only list, and stronger hospital transparency requirements.
Good write-up from @RebeccaMPifer on the @transparency_rx panel on the trajectory of PBM reform featuring Alejandro Molina, @reed_showalter, @CharlieKatebi, and @ConorSheehey https://t.co/b95nHIVY8v
Do you know how safe all of the hard-to-pronounce ingredients in your groceries are?
There’s a good chance that neither does the FDA because food manufacturers don’t need to tell them.
@A1Policy's @BobbyJindal & @CharlieKatebi are working to change that and close the loopholes and conflicts of interest in America’s food ingredient oversight programs.
Our new policy recommendation shows how! 👇
President Trump's historic executive order to lower American drug prices and end global freeloading on pharmaceutical innovation includes Major @A1Policy recommendations:
1. Using trade policy to end foreign price controls, and
2. Establishing Most-Favored-Nation drug pricing
President Trump’s "most-favored nation" drug pricing policy will tie U.S. drug costs to prices in other high-income countries, lowering costs for American seniors. As @CharlieKatebi explains, this approach will deliver savings faster than before. Read more: https://t.co/hNxxMLX6gr
@axios released a fantastic article on my new report on how Congress and the Administration can end global freeloading, accelerate American drug innovation, and lower drug prices. https://t.co/ISlTWsnGuO
Foreign nations harm sick Americans by undermining American innovation!
See more from AFPI's Governor Jindal & @CharlieKatebi in our recent report on how to stop global freeloading: https://t.co/3WHDOV0gH8
Wed, July 10:
Join AEI's @DrBrian4Health & panel of experts, many of whom served in prior administrations and Congress, to discuss the 2024 election & the future of health policy.
Panel: @brian_blase, @CharlieKatebi, Ryan Long, & Nina Owcharenko Schaefer
https://t.co/F8zzcYy6Xp
Medicare Advantage is getting worse because the Biden administration has introduced subtle changes that are steadily sabotaging the way the program functions, write @BobbyJindal and @CharlieKatebi
https://t.co/b5xAbmXDd1
Ever wonder why brand-name drugs charge such high prices? It's because many drug manufacturers abuse loopholes in America's patent system to block affordable generics so they can raise prices on working families. Patients Need commonsense patent reform https://t.co/EM53IMpowB
“If you see your doctor for a checkup you shouldn’t pay for a hospital visit. Patients & families deserve a #personaloption in health care that puts an end to dishonest billing & surprise unexpected costs,” said @CharlieKatebi, Sr. Policy Analyst, @AFPhq
https://t.co/JtjjT7Q4Jm
Through targeted digital ads, Americans for Prosperity is encouraging lawmakers to support site neutral payments. By utilizing digital media, we hope to encourage education, discussion, and overall support for this much-needed reform. @CharlieKatebi https://t.co/zs1gIEOAu8
"Lobbyists are pretty much the only opposition," @LorenAdler tells E&C committee of reforming Medicare payments to providers (site-neutral)
(while sitting next to American Hospital Association VP)
We’re proud to join a large coalition of policy leaders & think tanks from across the political spectrum, united in our effort to call for site-neutral payment reform in Medicare & greater transparency in hospital billing.
Our letter to Congress: https://t.co/EBb9dXBKqI